MacroGenics, Inc. (MGNX): Price and Financial Metrics
MGNX Price/Volume Stats
| Current price | $1.39 | 52-week high | $16.59 |
| Prev. close | $1.26 | 52-week low | $0.99 |
| Day low | $1.20 | Volume | 785,700 |
| Day high | $1.47 | Avg. volume | 739,616 |
| 50-day MA | $1.98 | Dividend yield | N/A |
| 200-day MA | $3.23 | Market Cap | 87.70M |
MGNX Stock Price Chart Interactive Chart >
MacroGenics, Inc. (MGNX) Company Bio
Macrogenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, as well as autoimmune disorders and infectious diseases. The company was founded in 2000 and is based in Rockville, Maryland.
MGNX Price Returns
| 1-mo | -30.33% |
| 3-mo | -54.87% |
| 6-mo | -61.39% |
| 1-year | -90.98% |
| 3-year | -82.20% |
| 5-year | -80.67% |
| YTD | -57.23% |
| 2024 | -66.22% |
| 2023 | 43.37% |
| 2022 | -58.19% |
| 2021 | -29.79% |
| 2020 | 110.11% |
Continue Researching MGNX
Want to do more research on Macrogenics Inc's stock and its price? Try the links below:Macrogenics Inc (MGNX) Stock Price | Nasdaq
Macrogenics Inc (MGNX) Stock Quote, History and News - Yahoo Finance
Macrogenics Inc (MGNX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...